Skip to content
  • Products & Services

    Our Products and Services

    See how bioAffinity Technologies is innovating the future of lung disease detection.

    CyPath® Lung

    Precision Pathology Laboratory Services

    Contact Us
    (210) 698-5334
    info@bioaffinitytech.com
    3300 Nacogdoches Road, Suite 216
    San Antonio, TX 78217

    Find us on X.com
    Find us on LinkedIn
  • Our Science

    Our Science

    See how we’re harnessing flow cytometry +AI to improve lives.

    Pipeline

    Medical & Scientific Advisory Board

    Publications & Scientific Presentations

    Contact Us
    (210) 698-5334
    info@bioaffinitytech.com
    3300 Nacogdoches Road, Suite 216
    San Antonio, TX 78217

    Find us on X.com
    Find us on LinkedIn
  • About

    About bioAffinity Technologies

    Learn more about bioAffinity Technologies.

    Executive Management

    Board of Directors

    Company History

    Statement from the CEO

    Contact Us
    (210) 698-5334
    info@bioaffinitytech.com
    3300 Nacogdoches Road, Suite 216
    San Antonio, TX 78217

    Find us on X.com
    Find us on LinkedIn
  • News & Videos

    News & Videos

    See what’s happening at bioAffinity Technologies.

    Press Releases

    News Articles

    Videos

    Contact Us
    (210) 698-5334
    info@bioaffinitytech.com
    3300 Nacogdoches Road, Suite 216
    San Antonio, TX 78217

    Find us on X.com
    Find us on LinkedIn
  • Investors
  • Contact Us

    Contact bioAffinity

    Reach out and let us know how we can help.

    Executive Offices

    Laboratories

    Sales

    Corporate Communications & Investor Relations

    Contact Us

    (210) 698-5334

    info@bioaffinitytech.com

    3300 Nacogdoches Road, Suite 216
    San Antonio, TX 78217

    Find us on X.com
    Find us on LinkedIn

Explore bioAffinity

News & Events, Publications, Videos and Press Releases

Sputum-Based Test May Identify Drug Targets in Asthma and COPD – Patient Care Online

  • March 8, 2026
Read More

New Test Shows Promise for Improving Lung Cancer Detection, Reducing Costs for VA – US Medicine, the Voice of Federal Medicine

  • August 29, 2025
Read More

bioAffinity Technologies Preps for Clinical Trial, Narrows Focus on its Lung Cancer Test

  • March 14, 2025
Read More

SA Biotech Plans Big Cuts to Grow Core Company

  • March 7, 2025
Read More

SA Company Sets the Stage for Asian Expansion

  • November 8, 2024
Read More

bioAffinity Would Consider Inbound Approaches Among Funding Options – Execs

  • October 16, 2024
Read More
Load More

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

  • May 12, 2026
Read More

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath® Lung into Pulmonary Practice

  • March 25, 2026
Read More

New Case Study: bioAffinity Technologies’ CyPath® Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedure

  • March 17, 2026
Read More

bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung

  • March 13, 2026
Read More

bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic

  • March 10, 2026
Read More

bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients

  • March 3, 2026
Read More

Recent Articles

Sputum-Based Test May Identify Drug Targets in Asthma and COPD – Patient Care Online

March 8, 2026

New Test Shows Promise for Improving Lung Cancer Detection, Reducing Costs for VA – US Medicine, the Voice of Federal Medicine

August 29, 2025

bioAffinity Technologies Preps for Clinical Trial, Narrows Focus on its Lung Cancer Test

March 14, 2025

SA Biotech Plans Big Cuts to Grow Core Company

March 7, 2025

SA Company Sets the Stage for Asian Expansion

November 8, 2024

bioAffinity Would Consider Inbound Approaches Among Funding Options – Execs

October 16, 2024

An investment in futures.

See how our approach delivers data-driven value to patients, healthcare
providers, and shareholders—driving meaningful impact and shaping more
promising futures.

Investors

Keep up with bioAffinity Technologies.

Join our mailing list.

Products & Services

  • CyPath® Lung
  • Precision Pathology Laboratory Services
  • CyPath® Lung
  • Precision Pathology Laboratory Services

Our Science

  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations
  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations

News & Events

  • Press Releases
  • News Articles
  • Videos
  • Press Releases
  • News Articles
  • Videos

Contact bioAffinity Technologies

  • Executive Offices
  • Laboratories
  • Sales
  • Corporate Communications & Investor Relations
  • Executive Offices
  • Laboratories
  • Sales
  • Corporate Communications & Investor Relations

Contact Us

(210) 698-5334

info@bioaffinitytech.com

3300 Nacogdoches Road, Suite 216

San Antonio, TX 78217

An investment in futures.

See how our approach delivers data-driven value to patients, healthcare providers, and shareholders—driving meaningful impact and shaping more
promising futures.

Get Involved

Keep up with
bioAffinity Technologies.

Join our mailing list.

Products & Services

  • CyPath® Lung
  • Precision Pathology Laboratory Services
  • CyPath® Lung
  • Precision Pathology Laboratory Services

Our Science

  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations
  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations

News & Videos

  • Press Releases
  • News Articles
  • Videos
  • Press Releases
  • News Articles
  • Videos

Contact bioAffinity

  • Executive Offices
  • Laboratories
  • Sales
  • Corporate Communications & Investor Relations
  • Executive Offices
  • Laboratories
  • Sales
  • Corporate Communications & Investor Relations

Contact Us

(210) 698-5334

info@bioaffinitytech.com

3300 Nacogdoches Road, Suite 216

San Antonio, TX 78217

Copyright © bioAffinity Technologies, Inc. 2026

Privacy Policy

Products and Services

View Our Products and Services

  • CyPath® Lung
  • Precision Pathology Laboratory Services
  • CyPath® Lung
  • Precision Pathology Laboratory Services
Our Science

Discover Our Science

  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations
  • Pipeline
  • Medical & Scientific Advisory Board
  • Publications & Scientific Presentations
About

Meet bioAffinity Technologies

  • Executive Management
  • Board of Directors
  • Company History
  • Statement from the CEO
  • Executive Management
  • Board of Directors
  • Company History
  • Statement from the CEO
News and Videos

Browse News and Videos

  • Press Releases
  • News Articles
  • Videos
  • Press Releases
  • News Articles
  • Videos
Investors

View Investor Relations

Contact

Contact Us
(210) 698-5334
info@bioaffinitytech.com
3300 Nacogdoches Road, Suite 216
San Antonio, TX 78217

Find us on X.com
Find us on LinkedIn